| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
interleukin 13 | 0.386 | 0.846 | 1.4E-02 |
|
phenotype | 0.310 | None | 1.000 | 1 | 0 | 2007 | 2013 | ||||||||
|
toll like receptor 2 | 0.361 | 0.923 | 1.0E-06 |
|
phenotype | 0.560 | None | 1.000 | 6 | 0 | 2005 | 2012 | ||||||||
|
toll like receptor 4 | 0.321 | 0.962 | 4.6E-09 |
|
phenotype | 0.350 | None | 1.000 | 5 | 0 | 2005 | 2012 | ||||||||
|
interleukin 17A | 0.324 | 0.923 | 4.3E-02 |
|
phenotype | 0.350 | None | 1.000 | 5 | 0 | 2003 | 2012 | ||||||||
|
plasminogen activator, urokinase receptor | 0.536 | 0.731 | 5.3E-03 |
|
phenotype | 0.310 | None | 1.000 | 1 | 0 | 2002 | 2012 | ||||||||
|
advanced glycosylation end-product specific receptor | 0.420 | 0.885 | 6.4E-16 |
|
phenotype | 0.310 | None | 1.000 | 1 | 0 | 2004 | 2012 | ||||||||
|
NLR family pyrin domain containing 3 | 0.361 | 0.962 | 8.1E-04 |
|
phenotype | 0.310 | None | 1.000 | 1 | 0 | 2002 | 2012 | ||||||||
|
C-reactive protein | 0.299 | 0.962 | 3.7E-03 |
|
phenotype | 0.600 | None | 1.000 | 15 | 0 | 2001 | 2011 | ||||||||
|
C-C motif chemokine ligand 2 | 0.321 | 0.962 | 0.61 |
|
phenotype | 0.540 | None | 1.000 | 4 | 0 | 2003 | 2011 | ||||||||
|
peroxisome proliferator activated receptor gamma | 0.358 | 0.885 | 2.9E-02 |
|
phenotype | 0.520 | None | 1.000 | 2 | 0 | 2006 | 2011 | ||||||||
|
transient receptor potential cation channel subfamily V member 1 | 0.446 | 0.885 | 1.0E-16 |
|
phenotype | 0.520 | None | 1.000 | 2 | 0 | 2007 | 2011 | ||||||||
|
TNF superfamily member 15 | 0.531 | 0.692 | 2.8E-03 |
|
phenotype | 0.310 | None | 1.000 | 1 | 0 | 2004 | 2011 | ||||||||
|
peroxisome proliferator activated receptor alpha | 0.432 | 0.885 | 3.0E-02 |
|
phenotype | 0.310 | None | 1.000 | 1 | 0 | 2004 | 2011 | ||||||||
|
apolipoprotein A1 | 0.429 | 0.885 | 5.5E-04 |
|
phenotype | 0.310 | None | 1.000 | 1 | 0 | 2008 | 2011 | ||||||||
|
transforming growth factor beta 1 | 0.287 | 0.962 | 3.7E-02 |
|
phenotype | 0.380 | None | 1.000 | 8 | 0 | 2002 | 2010 | ||||||||
|
macrophage migration inhibitory factor | 0.412 | 0.885 | 1.2E-02 |
|
phenotype | 0.560 | None | 1.000 | 6 | 0 | 2003 | 2010 | ||||||||
|
brain derived neurotrophic factor | 0.345 | 0.923 | 0.66 |
|
phenotype | 0.530 | None | 1.000 | 3 | 0 | 2003 | 2010 | ||||||||
|
bradykinin receptor B1 | 0.619 | 0.731 | 4.7E-03 |
|
phenotype | 0.310 | None | 1.000 | 1 | 0 | 2005 | 2010 | ||||||||
|
fibroblast growth factor 2 | 0.383 | 0.923 | 1.8E-02 |
|
phenotype | 0.510 | None | 1.000 | 1 | 0 | 2002 | 2010 | ||||||||
|
bradykinin receptor B2 | 0.585 | 0.808 | 0.12 |
|
phenotype | 0.510 | None | 1.000 | 1 | 0 | 1995 | 2010 | ||||||||
|
coagulation factor II thrombin receptor | 0.444 | 0.846 | 8.5E-03 |
|
phenotype | 0.310 | None | 1.000 | 1 | 0 | 2007 | 2010 | ||||||||
|
lipocalin 2 | 0.405 | 0.885 | 1.1E-09 |
|
phenotype | 0.310 | None | 1.000 | 1 | 0 | 2005 | 2010 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
phenotype | 0.570 | None | 1.000 | 7 | 0 | 2001 | 2009 | ||||||||
|
adiponectin, C1Q and collagen domain containing | 0.376 | 0.885 | 4.6E-09 |
|
phenotype | 0.360 | None | 1.000 | 6 | 0 | 2003 | 2009 | ||||||||
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
phenotype | 0.330 | None | 1.000 | 3 | 0 | 2004 | 2009 |